SN BioScience
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer (NCT07391813) | SN BioScience | 2026-03-01 |
| Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors (NCT04640480) | SN BioScience | 2020-10-21 |
Track SN BioScience automatically
Every clearance here is in the API, with alerts when new ones post.